My brother has been told that unless it can be demonstrated that there is less than a 1% risk of his experiencing a cerebral metatastic-related acute incapacitation he will not be allowed to return to work until 24 months post-treatment, in line with the improved prognosis at 24 months. The report from the neurosurgeon that his employer referred his scans, reports etc etc to, contains references backing up this position. Mention was made of BCL2+ and the reduced consequent prognosis of HPV 16 when it is present. Does anyone know what that is?

Brother 49yo DX 22/6/11 Tonsil SCC HPV+ Stage IV T4N1(?)M0. Carbo/docetaxel (Taxotere)19/7, 11/8 (with E-tux), 1/9; E-tux 11/8, 25/8, 15/9, 30/9, 14/10, 28/10; IMRT X 35 (70gy tumour;63gy nodes;56gy gen area) 19/9-4/11/11. Clear PET scan 1/2/12. 1 and 2 year post treatment checks good.